Lipidomics is a comprehensive and systematic analysis and identification of lipids and the molecules that interact with them in organisms, tissues or cells, to understand the structure and function of lipids, and to reveal the relationship between lipid metabolism and cells and organs. A discipline that covers the relationship between physiological and pathological processes of the body. At present, lipidomics has been widely used in important fields such as drug research and development, molecular physiology, molecular pathology, functional genomics, nutrition, environment and health.

The global Lipid Analysis Systems market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Lipid Analysis Systems Industry Forecast” looks at past sales and reviews total world Lipid Analysis Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Lipid Analysis Systems sales for 2023 through 2029. With Lipid Analysis Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Analysis Systems industry.

This Insight Report provides a comprehensive analysis of the global Lipid Analysis Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Analysis Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Analysis Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Analysis Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Analysis Systems.

• United States market for Lipid Analysis Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
• China market for Lipid Analysis Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
• Europe market for Lipid Analysis Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Lipid Analysis Systems players cover:

• Purspec
• Agilent
• BGI
• Bruker
• Oebiotech

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Analysis Systems market by product type, application, key players and key regions and countries.

1. Segmentation by Type:
• Equipment
• Service
2. Segmentation by Application:
• Drug Discovery
• Biomarker Discovery
• Personalized Medicine
• Diagnosis & Treatment
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• Purspec
• Agilent
• BGI
• Bruker
• Oebiotech
• SCIEX
• Waters
• Merck
• Thermo Fisher Scientific